Search by Drug Name or NDC
NDC 68047-0253-01 OSCIMIN 0.125 mg/1 Details
OSCIMIN 0.125 mg/1
OSCIMIN is a SUBLINGUAL TABLET, ORALLY DISINTEGRATING in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Larken Laboratories, Inc.. The primary component is HYOSCYAMINE SULFATE.
MedlinePlus Drug Summary
Hyoscyamine is used to control symptoms associated with disorders of the gastrointestinal (GI) tract. It works by decreasing the motion of the stomach and intestines and the secretion of stomach fluids, including acid. Hyoscyamine is also used in the treatment of bladder spasms, peptic ulcer disease, diverticulitis, colic, irritable bowel syndrome, cystitis, and pancreatitis. Hyoscyamine may also be used to treat certain heart conditions, to control the symptoms of Parkinson's disease and rhinitis (runny nose), and to reduce excess saliva production.
Related Packages: 68047-0253-01Last Updated: 12/01/2022
MedLinePlus Full Drug Details: Hyoscyamine
Product Information
| NDC | 68047-0253 |
|---|---|
| Product ID | 68047-253_07740fcc-9b17-770f-e063-6394a90aa947 |
| Associated GPIs | 49101030100710 |
| GCN Sequence Number | 004868 |
| GCN Sequence Number Description | hyoscyamine sulfate TAB SUBL 0.125 MG SUBLINGUAL |
| HIC3 | J2A |
| HIC3 Description | BELLADONNA ALKALOIDS |
| GCN | 18970 |
| HICL Sequence Number | 002017 |
| HICL Sequence Number Description | HYOSCYAMINE SULFATE |
| Brand/Generic | Generic |
| Proprietary Name | OSCIMIN |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | Hyoscyamine Sulfate |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | TABLET, ORALLY DISINTEGRATING |
| Route | SUBLINGUAL |
| Active Ingredient Strength | 0.125 |
| Active Ingredient Units | mg/1 |
| Substance Name | HYOSCYAMINE SULFATE |
| Labeler Name | Larken Laboratories, Inc. |
| Pharmaceutical Class | n/a |
| DEA Schedule | n/a |
| Marketing Category | UNAPPROVED DRUG OTHER |
| Application Number | n/a |
| Listing Certified Through | 2024-12-31 |
Package
NDC 68047-0253-01 (68047025301)
| NDC Package Code | 68047-253-01 |
|---|---|
| Billing NDC | 68047025301 |
| Package | 100 TABLET, ORALLY DISINTEGRATING in 1 BOTTLE (68047-253-01) |
| Marketing Start Date | 2011-08-03 |
| NDC Exclude Flag | N |
| Pricing Information | |
| Price Per Unit | 0.15102 |
| Pricing Unit | EA |
| Effective Date | 2024-02-21 |
| NDC Description | OSCIMIN SL 0.125 MG TABLET |
| Pharmacy Type Indicator | C/I |
| OTC | N |
| Explanation Code | 1 |
| Classification for Rate Setting | G |
| As of Date | 2024-02-21 |